Facebook link Linked In link You Tube link

Interventional Immunology 2013
Attendee List & Slides 

Attendee List

Slides 
B Cell Targeting in Chronic Inflammation: An Update - John Looney, MD, University of Rochester 
  Part I
  Part II 
  Part III

JAK Inhibitors: Bench to Bedside - John O'Shea, MD, National Institutes of Health (SLIDES FORTHCOMING) 

Modulating the Immune System in Type 1 Diabetes - Mark Anderson, MD, PhD, University of California, San Francisco

Bringing Biomarkers into Clinical Trials and Clinical Practice - Scott Plevy, MD, University of North Carolina at Chapel Hill (SLIDES FORTHCOMING) 

Immune Intervention in Psoriasis: IL-12, IL-23, IL-17 or all of the Above? - James Krueger, MD, PhD, Rockefellar University
  Part I
  Part II
  Part III
  Part IV
  Part V

Lymphocyte Depletion in Transplantation: Mechanisms of Tolerance and Clinical Outcomes - Laurence Turka, MD, Massachusetts General Hospital
  Part I
  Part II
  Part III

Targeting Chemokines in Inflammation and Allergy - Andrew Luster, Massachusetts General Hospital
  Part I
  Part II
  Part III
  Part IV
  Part V

Share